UMass Chan Receives $14.7 Million Grant to Develop Gene Therapies for Alpha-1 Antitrypsin Deficiency
September 11, 2026
September 11, 2026
WORCESTER, Massachusetts, Sept. 11 -- The University of Massachusetts Chan Medical School issued the following news:
* * *
UMass Chan receives $14.7 million grant to develop gene therapies for alpha-1 antitrypsin deficiency
Investigators seek to improve vector design and potency for gene replacement delivery
September 10, 2026
At a glance
* UMass Chan Medical School receives $14.7 million grant to improve gene therapy . . .
* * *
UMass Chan receives $14.7 million grant to develop gene therapies for alpha-1 antitrypsin deficiency
Investigators seek to improve vector design and potency for gene replacement delivery
September 10, 2026
At a glance
* UMass Chan Medical School receives $14.7 million grant to improve gene therapy . . .